Douglas R. Spitz
10Patents
3h-index
25Co-inventors
56Inventor score
Filing activity: Apr 27, 2009 → Nov 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9801922B2 | Compositions and methods of treating cancer | Human Necessities | 14 | Active |
| US11219614B2 | Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound | Human Necessities | 5 | Active |
| US10052304B2 | Compositions and methods for cancer therapy | Human Necessities | 4 | Active |
| US8841423B2 | Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II | Physics | 2 | Active |
| US9168307B2 | Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity | Human Necessities | 1 | Active |
| US9090701B2 | Methods of detecting oxidized calcium/calmodulin dependent protein kinase II | Physics | 1 | Active |
| US11596613B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US12220420B2 | Combination therapy for cancer treatment | Human Necessities | 0 | Active |
| US12156863B2 | Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound | Human Necessities | 0 | Active |
| US11529335B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.